Condition
Non-CF Bronchiectasis
Total Trials
4
Recruiting
3
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Recruiting3
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06985225Recruiting
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
NCT04793867Recruiting
Regional Phenotyping of CF and Non-CF Bronchiectasis
NCT01822834RecruitingPrimary
Bronchiectasis and NTM Research Registry
NCT02657473Phase 2CompletedPrimary
Inhaled Nebulized Tobramycin in Non-cystic Fibrosis Bronchiectasis
Showing all 4 trials